毒副作用-话题@MedSci

#毒副作用#

20篇内容 | 556人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2078801, encodeId=050320e880123, content=<a href='/topic/show?id=6dbc635680d' target=_blank style='color:#2F92EE;'>#毒副作用#</a>, objectTitle=Cell：重磅！下一代更智能的细胞疗法出炉！表达模块化SNIPR受体的CAR-T细胞可高效杀死实体瘤，同时减少毒副作用, objectType=article, longId=724648, objectId=6f1ce2464888, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f1ce2464888, replyNumber=0, likeNumber=40, createdTime=2023-03-08, rootId=0, userName=liuyong2980, userId=de89102, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f1ce2464888, moduleTitle=Cell：重磅！下一代更智能的细胞疗法出炉！表达模块化SNIPR受体的CAR-T细胞可高效杀死实体瘤，同时减少毒副作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f1ce2464888)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2078800, encodeId=b9b920e880057, content=<a href='/topic/show?id=6dbc635680d' target=_blank style='color:#2F92EE;'>#毒副作用#</a>, objectTitle=J Clin Oncol：3期| 图像引导的调化放疗 vs 3D适形放疗用于宫颈癌术后患者的晚期毒副作用, objectType=article, longId=292999, objectId=f768292999f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f768292999f9, replyNumber=0, likeNumber=35, createdTime=2022-10-06, rootId=0, userName=liuyong2980, userId=de89102, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f768292999f9, moduleTitle=J Clin Oncol：3期| 图像引导的调化放疗 vs 3D适形放疗用于宫颈癌术后患者的晚期毒副作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f768292999f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2078799, encodeId=a65c20e87997f, content=<a href='/topic/show?id=6dbc635680d' target=_blank style='color:#2F92EE;'>#毒副作用#</a>, objectTitle=J Clin Oncol：3期| 图像引导的调化放疗 vs 3D适形放疗用于宫颈癌术后患者的晚期毒副作用, objectType=article, longId=216977, objectId=32c82169e7ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=32c82169e7ba, replyNumber=0, likeNumber=34, createdTime=2022-05-17, rootId=0, userName=liuyong2980, userId=de89102, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=32c82169e7ba, moduleTitle=J Clin Oncol：3期| 图像引导的调化放疗 vs 3D适形放疗用于宫颈癌术后患者的晚期毒副作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=32c82169e7ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2078798, encodeId=c60e20e87989a, content=<a href='/topic/show?id=6dbc635680d' target=_blank style='color:#2F92EE;'>#毒副作用#</a>, objectTitle=上皮性卵巢癌化疗和PARPi治疗相关血液学毒副作用：临床表现，诊断和管理, objectType=article, longId=206531, objectId=7bc9206531c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7bc9206531c8, replyNumber=0, likeNumber=40, createdTime=2021-02-24, rootId=0, userName=liuyong2980, userId=de89102, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7bc9206531c8, moduleTitle=上皮性卵巢癌化疗和PARPi治疗相关血液学毒副作用：临床表现，诊断和管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7bc9206531c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2078797, encodeId=59a420e87971a, content=<a href='/topic/show?id=6dbc635680d' target=_blank style='color:#2F92EE;'>#毒副作用#</a>, objectTitle=ASCO 2020：低免疫毒副作用的PD-L1抗体令人叹服, objectType=article, longId=195027, objectId=24f119502e0a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=24f119502e0a, replyNumber=0, likeNumber=36, createdTime=2021-02-11, rootId=0, userName=liuyong2980, userId=de89102, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=24f119502e0a, moduleTitle=ASCO 2020：低免疫毒副作用的PD-L1抗体令人叹服, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=24f119502e0a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2078796, encodeId=34f520e8796d1, content=<a href='/topic/show?id=6dbc635680d' target=_blank style='color:#2F92EE;'>#毒副作用#</a>, objectTitle=化疗引发基因突变？癌症治疗毒副作用关键机制首次揭秘！, objectType=article, longId=184096, objectId=0b3a18409604, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b3a18409604, replyNumber=0, likeNumber=50, createdTime=2020-03-22, rootId=0, userName=liuyong2980, userId=de89102, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b3a18409604, moduleTitle=化疗引发基因突变？癌症治疗毒副作用关键机制首次揭秘！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b3a18409604)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2078795, encodeId=8c3520e879507, content=<a href='/topic/show?id=6dbc635680d' target=_blank style='color:#2F92EE;'>#毒副作用#</a>, objectTitle=Nat Genet：化疗引发基因突变？癌症治疗毒副作用关键机制首次揭秘！, objectType=article, longId=183404, objectId=84b11834048b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=84b11834048b, replyNumber=0, likeNumber=32, createdTime=2020-03-27, rootId=0, userName=liuyong2980, userId=de89102, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=84b11834048b, moduleTitle=Nat Genet：化疗引发基因突变？癌症治疗毒副作用关键机制首次揭秘！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=84b11834048b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2078794, encodeId=666020e879449, content=<a href='/topic/show?id=6dbc635680d' target=_blank style='color:#2F92EE;'>#毒副作用#</a>, objectTitle=由于毒副作用，欧洲药品管理局建议限制Lemtrada在多发性硬化症中的使用, objectType=article, longId=164344, objectId=ad231643441f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad231643441f, replyNumber=0, likeNumber=41, createdTime=2019-05-06, rootId=0, userName=liuyong2980, userId=de89102, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad231643441f, moduleTitle=由于毒副作用，欧洲药品管理局建议限制Lemtrada在多发性硬化症中的使用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ad231643441f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2078793, encodeId=61ce20e8793e1, content=<a href='/topic/show?id=6dbc635680d' target=_blank style='color:#2F92EE;'>#毒副作用#</a>, objectTitle=Lancet oncol：根据DPYD基因型适当降低尿嘧啶剂量可减少其毒副作用, objectType=article, longId=152212, objectId=d5fd1522124a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d5fd1522124a, replyNumber=0, likeNumber=31, createdTime=2019-03-24, rootId=0, userName=liuyong2980, userId=de89102, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d5fd1522124a, moduleTitle=Lancet oncol：根据DPYD基因型适当降低尿嘧啶剂量可减少其毒副作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d5fd1522124a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2078792, encodeId=faf920e8792e0, content=<a href='/topic/show?id=6dbc635680d' target=_blank style='color:#2F92EE;'>#毒副作用#</a>, objectTitle=Lancet oncol：Tucatinib联合卡培他滨、曲妥珠单抗治疗HER2阳性的进展期乳腺癌患者，毒副作用可接受，且具有抗肿瘤效果, objectType=article, longId=139112, objectId=33c3139112e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=33c3139112e3, replyNumber=0, likeNumber=38, createdTime=2018-11-30, rootId=0, userName=liuyong2980, userId=de89102, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=33c3139112e3, moduleTitle=Lancet oncol：Tucatinib联合卡培他滨、曲妥珠单抗治疗HER2阳性的进展期乳腺癌患者，毒副作用可接受，且具有抗肿瘤效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=33c3139112e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2078791, encodeId=ef1d20e87919f, content=<a href='/topic/show?id=6dbc635680d' target=_blank style='color:#2F92EE;'>#毒副作用#</a>, objectTitle=Blood：NUDT15基因型指导MP剂量个体化可在不影响治疗效果的前体下降低其相关毒副作用, objectType=article, longId=133566, objectId=45dc133566ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=45dc133566ff, replyNumber=0, likeNumber=45, createdTime=2018-04-27, rootId=0, userName=liuyong2980, userId=de89102, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=45dc133566ff, moduleTitle=Blood：NUDT15基因型指导MP剂量个体化可在不影响治疗效果的前体下降低其相关毒副作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=45dc133566ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2078790, encodeId=8a6a20e8790fe, content=<a href='/topic/show?id=6dbc635680d' target=_blank style='color:#2F92EE;'>#毒副作用#</a>, objectTitle=Rsc Advances：监测抗癌药物毒副作用的“体内芯片”装置, objectType=article, longId=111154, objectId=4b3011115430, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4b3011115430, replyNumber=0, likeNumber=41, createdTime=2018-06-04, rootId=0, userName=liuyong2980, userId=de89102, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4b3011115430, moduleTitle=Rsc Advances：监测抗癌药物毒副作用的“体内芯片”装置, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4b3011115430)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2078788, encodeId=cb8820e878832, content=<a href='/topic/show?id=6dbc635680d' target=_blank style='color:#2F92EE;'>#毒副作用#</a>, objectTitle=Nat Med：肿瘤免疫学的毒副作用, objectType=article, longId=98277, objectId=b734982e71d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b734982e71d, replyNumber=0, likeNumber=47, createdTime=2017-12-28, rootId=0, userName=liuyong2980, userId=de89102, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b734982e71d, moduleTitle=Nat Med：肿瘤免疫学的毒副作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b734982e71d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2078789, encodeId=72d720e878949, content=<a href='/topic/show?id=6dbc635680d' target=_blank style='color:#2F92EE;'>#毒副作用#</a>, objectTitle=Cancer Res：研究表明注射肿瘤抑制因子激活剂直达病灶，大大降低毒副作用！, objectType=article, longId=99541, objectId=f29499541fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f29499541fd, replyNumber=0, likeNumber=36, createdTime=2018-01-14, rootId=0, userName=liuyong2980, userId=de89102, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f29499541fd, moduleTitle=Cancer Res：研究表明注射肿瘤抑制因子激活剂直达病灶，大大降低毒副作用！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f29499541fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2078787, encodeId=b97e20e8787b1, content=<a href='/topic/show?id=6dbc635680d' target=_blank style='color:#2F92EE;'>#毒副作用#</a>, objectTitle=Oncotarget：新型无毒副作用疗法可治疗多种癌症, objectType=article, longId=68767, objectId=3a9368e67c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3a9368e67c8, replyNumber=0, likeNumber=48, createdTime=2017-01-07, rootId=0, userName=liuyong2980, userId=de89102, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3a9368e67c8, moduleTitle=Oncotarget：新型无毒副作用疗法可治疗多种癌症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3a9368e67c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2078786, encodeId=c79a20e8786ae, content=<a href='/topic/show?id=6dbc635680d' target=_blank style='color:#2F92EE;'>#毒副作用#</a>, objectTitle=Lancet Oncol：半胸放疗对于恶性胸膜间皮瘤无显著疗效且毒副作用强, objectType=article, longId=58459, objectId=c6935845915, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c6935845915, replyNumber=0, likeNumber=37, createdTime=2016-06-24, rootId=0, userName=liuyong2980, userId=de89102, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c6935845915, moduleTitle=Lancet Oncol：半胸放疗对于恶性胸膜间皮瘤无显著疗效且毒副作用强, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c6935845915)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2078785, encodeId=9b0f20e87850e, content=<a href='/topic/show?id=6dbc635680d' target=_blank style='color:#2F92EE;'>#毒副作用#</a>, objectTitle=NEJM：丙肝药索非布韦对心脏有潜在的毒副作用？, objectType=article, longId=58412, objectId=d86f58412df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d86f58412df, replyNumber=0, likeNumber=40, createdTime=2016-07-28, rootId=0, userName=liuyong2980, userId=de89102, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d86f58412df, moduleTitle=NEJM：丙肝药索非布韦对心脏有潜在的毒副作用？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d86f58412df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2078784, encodeId=239a20e87849b, content=<a href='/topic/show?id=6dbc635680d' target=_blank style='color:#2F92EE;'>#毒副作用#</a>, objectTitle=JCO：地磷莫司治疗晚期子宫内膜癌是有效的，但毒副作用太大, objectType=article, longId=58171, objectId=6785581e140, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6785581e140, replyNumber=0, likeNumber=60, createdTime=2016-07-22, rootId=0, userName=liuyong2980, userId=de89102, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6785581e140, moduleTitle=JCO：地磷莫司治疗晚期子宫内膜癌是有效的，但毒副作用太大, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6785581e140)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2078783, encodeId=61ae20e878347, content=<a href='/topic/show?id=6dbc635680d' target=_blank style='color:#2F92EE;'>#毒副作用#</a>, objectTitle=Cancer Cell：旧研究，新方法，新型抗癌药物无任何毒副作用！, objectType=article, longId=41329, objectId=9360413293b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9360413293b, replyNumber=0, likeNumber=31, createdTime=2015-04-10, rootId=0, userName=liuyong2980, userId=de89102, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9360413293b, moduleTitle=Cancer Cell：旧研究，新方法，新型抗癌药物无任何毒副作用！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9360413293b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2078782, encodeId=b1a320e87828a, content=<a href='/topic/show?id=6dbc635680d' target=_blank style='color:#2F92EE;'>#毒副作用#</a>, objectTitle=徐鹭英：鼻咽癌放疗后的远期毒副作用, objectType=article, longId=3519, objectId=affa3519b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=affa3519b4, replyNumber=0, likeNumber=45, createdTime=2012-01-15, rootId=0, userName=liuyong2980, userId=de89102, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=affa3519b4, moduleTitle=徐鹭英：鼻咽癌放疗后的远期毒副作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=affa3519b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

毒副作用

2020-05-29

liuyong2980 (审核中...)

前往app查看评论内容

#毒副作用#

Cell：重磅！下一代更智能的细胞疗法出炉！表达模块化SNIPR受体的CAR-T细胞可高效杀死实体瘤，同时减少毒副作用

2023-03-08

liuyong2980 (审核中...)

前往app查看评论内容

#毒副作用#

J Clin Oncol：3期| 图像引导的调化放疗 vs 3D适形放疗用于宫颈癌术后患者的晚期毒副作用

2022-10-06

liuyong2980 (审核中...)

前往app查看评论内容

#毒副作用#

J Clin Oncol：3期| 图像引导的调化放疗 vs 3D适形放疗用于宫颈癌术后患者的晚期毒副作用

2022-05-17

liuyong2980 (审核中...)

前往app查看评论内容

#毒副作用#

上皮性卵巢癌化疗和PARPi治疗相关血液学毒副作用：临床表现，诊断和管理

2021-02-24

liuyong2980 (审核中...)

前往app查看评论内容

#毒副作用#

ASCO 2020：低免疫毒副作用的PD-L1抗体令人叹服

2021-02-11

liuyong2980 (审核中...)

前往app查看评论内容

#毒副作用#

化疗引发基因突变？癌症治疗毒副作用关键机制首次揭秘！

2020-03-22

liuyong2980 (审核中...)

前往app查看评论内容

#毒副作用#

Nat Genet：化疗引发基因突变？癌症治疗毒副作用关键机制首次揭秘！

2020-03-27

liuyong2980 (审核中...)

前往app查看评论内容

#毒副作用#

由于毒副作用，欧洲药品管理局建议限制Lemtrada在多发性硬化症中的使用

2019-05-06

liuyong2980 (审核中...)

前往app查看评论内容

#毒副作用#

Lancet oncol：根据DPYD基因型适当降低尿嘧啶剂量可减少其毒副作用

2019-03-24

liuyong2980 (审核中...)

前往app查看评论内容

#毒副作用#

Lancet oncol：Tucatinib联合卡培他滨、曲妥珠单抗治疗HER2阳性的进展期乳腺癌患者，毒副作用可接受，且具有抗肿瘤效果

2018-11-30

liuyong2980 (审核中...)

前往app查看评论内容

#毒副作用#

Blood：NUDT15基因型指导MP剂量个体化可在不影响治疗效果的前体下降低其相关毒副作用

2018-04-27

liuyong2980 (审核中...)

前往app查看评论内容

#毒副作用#

Rsc Advances：监测抗癌药物毒副作用的“体内芯片”装置

2018-06-04

liuyong2980 (审核中...)

前往app查看评论内容

#毒副作用#

Nat Med：肿瘤免疫学的毒副作用

2017-12-28

liuyong2980 (审核中...)

前往app查看评论内容

#毒副作用#

Cancer Res：研究表明注射肿瘤抑制因子激活剂直达病灶，大大降低毒副作用！

2018-01-14

liuyong2980 (审核中...)

前往app查看评论内容

#毒副作用#

Oncotarget：新型无毒副作用疗法可治疗多种癌症

2017-01-07

liuyong2980 (审核中...)

前往app查看评论内容

#毒副作用#

Lancet Oncol：半胸放疗对于恶性胸膜间皮瘤无显著疗效且毒副作用强

2016-06-24

liuyong2980 (审核中...)

前往app查看评论内容

#毒副作用#

NEJM：丙肝药索非布韦对心脏有潜在的毒副作用？

2016-07-28

liuyong2980 (审核中...)

前往app查看评论内容

#毒副作用#

JCO：地磷莫司治疗晚期子宫内膜癌是有效的，但毒副作用太大

2016-07-22

liuyong2980 (审核中...)

前往app查看评论内容

#毒副作用#

Cancer Cell：旧研究，新方法，新型抗癌药物无任何毒副作用！

2015-04-10

liuyong2980 (审核中...)

前往app查看评论内容

#毒副作用#

徐鹭英：鼻咽癌放疗后的远期毒副作用

2012-01-15

科室
- - 订阅+
  - 更多科室
工具
服务